← Open Payments lookup

STEVEN STEIN: Open Payments

NPI 1417319104 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$886 in 34 payments from 15 companies in 2025. Trend: 2023 $417 · 2024 $275 · 2025 $886

Food & beverage: $886
CompanyPaymentsAmount
Alkermes, Inc.5$135
ABBVIE INC.4$114
Otsuka America Pharmaceutical, Inc.4$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$87
E.R. Squibb & Sons, L.L.C.4$82
Vanda Pharmaceuticals Inc.2$68
Janssen Pharmaceuticals, Inc2$65
Takeda Pharmaceuticals U.S.A., Inc.1$37
Axsome Therapeutics, Inc.2$36
Collegium Pharmaceutical, Inc.2$36

Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, ARISTADA, FANAPT, SPRAVATO, TRINTELLIX.

Industry payments across FL — which companies pay providers there.